The FDA-approved system is designed for providing moderate sedation to patients undergoing select gastrointestinal procedures, such as screening colonoscopy or EGD.
“It really allows us to use propofol, which we believe is superior to midazolam and fentanyl, in outpatients without having the added cost of having anesthesiologists administer [the drug],” said gastroenterologist Otto Lin, MD, according to the report.
More articles on gastroenterology:
The biggest threats to success in the GI field
9 GI physicians earning honors
6 GI physicians in the news
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
